zidovudine has been researched along with Disseminated Fungal Infection in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aguilar, C; Avettand-Fenoel, V; Bougnoux, ME; Frenzel, L; Guery, R; Helias, P; Hermine, O; Lanternier, F; Lecuit, M; Lecuyer, H; Lortholary, O; Marçais, A; Raphalen, JH; Renaudier, P; Santa, F; Sibon, D; Suarez, F | 1 |
1 other study(ies) available for zidovudine and Disseminated Fungal Infection
| Article | Year |
|---|---|
Poor outcome and high prevalence of invasive fungal infections in patients with adult T-cell leukemia/lymphoma exposed to zidovudine and interferon alfa.
Topics: Adolescent; Adult; Aged; Antibiotic Prophylaxis; Antineoplastic Combined Chemotherapy Protocols; Aspergillosis; Febrile Neutropenia; Female; Fever of Unknown Origin; Fungemia; Humans; Interferon-alpha; Invasive Fungal Infections; Kaplan-Meier Estimate; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Opportunistic Infections; Pneumonia, Pneumocystis; Prevalence; Prognosis; Retrospective Studies; Strongyloidiasis; Treatment Outcome; Young Adult; Zidovudine | 2021 |